Bemarituzumab
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Bemarituzumab, covering 2022-05-24 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer [Phase 1, Phase 2]